| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 05/13/2009 | EP1912957A4 Ep4 receptor agonist, compositions and methods thereof |
| 05/13/2009 | EP1687301B1 Thiaepothilone for treating cancerous diseases |
| 05/13/2009 | EP1587795B1 N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as cgrp-antagonists for treating a headache |
| 05/13/2009 | EP1549624B1 Inhibitors of fatty acid amide hydrolase |
| 05/13/2009 | EP1535616B1 Remedy for integration dysfunction syndrome |
| 05/13/2009 | EP1355646B1 Muscarinic receptor agonists |
| 05/13/2009 | EP1252140B1 Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 05/13/2009 | EP0934311B1 New heterocyclylmethyl-substituted pyrazol derivates |
| 05/13/2009 | CN101432283A N- (2-thiazolyl) -amide derivatives as GSK-3 inhibitors |
| 05/13/2009 | CN101432282A N- (2-thiazolyl) -amide derivatives as GSK-3 inhibitors |
| 05/13/2009 | CN101432281A 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling |
| 05/13/2009 | CN101432278A Diketo-piperazine and piperidine derivatives as antiviral agents |
| 05/13/2009 | CN101429170A Biaryl heterocyclic compounds and methods of making and using the same |
| 05/13/2009 | CN100486973C Novel benzodioxoles |
| 05/12/2009 | US7531566 Anti-inflammatory medicaments |
| 05/12/2009 | US7531564 Substituted benzoxazoles as estrogenic agents |
| 05/12/2009 | US7531561 GSK-3 inhibitors |
| 05/12/2009 | US7531559 Fungicidal 1,2,3 triazole derivatives |
| 05/12/2009 | US7531558 Carboxamide derivatives |
| 05/12/2009 | US7531557 oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; alcoholism; 6-(2-Fluoro-4-{[2-(tetrahydro-pyran-4-yl)-ethylamino]-methyl}-phenoxy)-nicotinamide |
| 05/12/2009 | US7531542 Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor |
| 05/12/2009 | US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide |
| 05/12/2009 | US7531538 α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531534 e.g. N-{3-[(S)-5-tert-Butyl-1-(3-chloro-4-fluoro-benzyl)-4-hydroxy-2-oxo-2,5-dihydro-1H-pyrrol-3-yl]-2-chloro-1,1-dioxo-1,4-dihydro-1 lambda 6-benzo[1,4]thiazin-7-yl}-methanesulfonamide; viricide; hepatitis C virus polymerase inhibitor |
| 05/12/2009 | CA2475302C Controlled synthesis of ziprasidone and compositions thereof |
| 05/12/2009 | CA2428604C Microbiocidal n-phenyl-n-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives |
| 05/12/2009 | CA2278553C Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulators |
| 05/12/2009 | CA2264005C Piperazino derivatives as neurokinin antagonists |
| 05/07/2009 | WO2009059243A1 Treating and preventing viral infections |
| 05/07/2009 | WO2009058739A1 Heterocyclic urea and thiourea derivatives and methods of use thereof |
| 05/07/2009 | WO2009058730A1 Diamido thiazole derivatives as protein kinase inhibitors |
| 05/07/2009 | WO2009058728A1 Thiazole derivatives as protein kinase inhibitors |
| 05/07/2009 | WO2009058348A1 Amide derivatives as sirtuin modulators |
| 05/07/2009 | WO2009057827A1 Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors |
| 05/07/2009 | WO2009056811A2 Tetrahydrobenzothiazole derivatives with dopamine receptor activity |
| 05/07/2009 | WO2009056805A1 Medicaments |
| 05/07/2009 | WO2009056693A1 Novel derivatives of n, n'- 2, 4-dianilinopyrimidines, preparation thereof as medicaments pharmaceutical compositions and in particular as ikk inhibitors |
| 05/07/2009 | WO2009036341A3 Compositions and methods relating to hiv protease inhibition |
| 05/07/2009 | WO2009030952A3 Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway |
| 05/07/2009 | WO2009025983A3 Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives |
| 05/07/2009 | WO2009024287A3 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |
| 05/07/2009 | WO2009006389A3 Pyrimidine derivatives useful as raf kinase inhibitors |
| 05/07/2009 | WO2006047277A3 Inhibitors of c-fms kinase |
| 05/07/2009 | US20090118514 Processes for preparing pioglitazone and its pharmaceutically acceptable salts |
| 05/07/2009 | US20090118506 6,11-bridged biaryl macrolides |
| 05/07/2009 | US20090118502 organic or inorganic salt of N-{3-[4'-(4-Aminomethyl-[1,2,3]triazol-1-ylmethyl)-2-fluoro-biphenyl- 4-yl]-2-oxo-oxazolidin-5-(S)-ylmethyl}-acetamide; anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents |
| 05/07/2009 | US20090118501 enzyme inhibitor for treating diabetes; 1-(4-Methyl-cyclohexyl)-3-(5-methyl-thiazol-2-yl)-1-(4-oxo-cyclohexyl)-urea |
| 05/07/2009 | US20090118336 Pyrazole derivatives and their use as pi3k inhibitors |
| 05/07/2009 | US20090118297 Polymorphs of dasatinib and process for preparation thereof |
| 05/07/2009 | US20090118296 Heteroaromatic Compounds As Inhibitors Of Stearoyl-Coenzyme A Delta-9 Desaturase |
| 05/07/2009 | US20090118295 Chemical compounds |
| 05/07/2009 | US20090118286 Heterobicyclic Acrylamides |
| 05/07/2009 | US20090118272 Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors |
| 05/07/2009 | US20090118270 Phosphodiesterase 4 inhibitors |
| 05/07/2009 | US20090118259 Pharmaceutical use of substituted amides |
| 05/07/2009 | US20090118233 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | US20090117074 Sulfonylpyrroles as Histone Deacetylase Inhibitors |
| 05/07/2009 | US20090114906 Materials for n-doping the electron-transporting layers in organic electronic components |
| 05/07/2009 | CA2704336A1 Amide derivatives as sirtuin modulators |
| 05/07/2009 | CA2703981A1 Heterocyclic urea and thiourea derivatives and methods of use thereof |
| 05/07/2009 | CA2703980A1 Diamido thiazole derivatives as protein kinase inhibitors |
| 05/07/2009 | CA2703979A1 Heterocyclic ether and thioether derivatives and methods of use thereof |
| 05/07/2009 | CA2703978A1 Thiazole derivatives as protein kinase inhibitors |
| 05/07/2009 | CA2700917A1 Novel pyrimidine derivatives |
| 05/07/2009 | CA2699631A1 Pyridazinone compounds and p2x7 receptor inhibitors |
| 05/06/2009 | EP2054410A2 Oxazolidone derivatives as pr modulators |
| 05/06/2009 | EP2054409A2 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
| 05/06/2009 | EP2054408A2 Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid level |
| 05/06/2009 | EP2054395A2 Piperazine compounds with a herbicidal action |
| 05/06/2009 | EP2054392A2 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha |
| 05/06/2009 | EP2054388A1 Viral polymerase inhibitors |
| 05/06/2009 | EP1945635B1 Thiazolyl piperidine derivatives useful as h3 receptor modulators |
| 05/06/2009 | EP1729774A4 Pyrrolidine compounds |
| 05/06/2009 | EP1725632A4 New materials for injecting or transporting holes and organic electroluminescence devices using the same |
| 05/06/2009 | EP1670757B1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 05/06/2009 | EP1670478A4 Heteroaromatic selective inhibitors of neuronal nitric oxide synthase |
| 05/06/2009 | EP1648878B1 Piperidine compounds and pharmaceutical compositions containing them |
| 05/06/2009 | EP1613156B1 N-phenyl- " (4-pyridyl)- azinyl]amine derivatives as plant protection agents |
| 05/06/2009 | EP1385506B1 Acylated piperidine derivates as melanocortin-4 receptor agonists |
| 05/06/2009 | EP1373265B1 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 05/06/2009 | EP1272193B1 Synergistic combination therapy for treating cancer |
| 05/06/2009 | CN101426789A 2-n-(5-[[4-(2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione) butanedioic acid, methods of preparation and compositions with rosiglitazone maleate |
| 05/06/2009 | CN101426788A Substituted pyrazinone derivatives for use as a medicine |
| 05/06/2009 | CN101426781A CCR5 antagonists useful for treating HIV |
| 05/06/2009 | CN101426779A Pesticides containing a bicyclic bisamide structure |
| 05/06/2009 | CN101426766A Novel heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors |
| 05/06/2009 | CN101426486A Compounds for the treatment of inflammatory disorders and microbial diseases |
| 05/06/2009 | CN101423516A Preparation of pidotimod sodium and medicinal use thereof |
| 05/06/2009 | CN101423500A Substituted benzoxazoles and analogues as estrogenic agents |
| 05/06/2009 | CN101423481A Diketohydrazine derivative compound and medicine containing the compound as active ingredient |
| 05/06/2009 | CN100484936C Synthesis of (2S,6R)-6-amino-2(2-thienyl)1,4-parathiazine-5-ketone |
| 05/06/2009 | CN100484935C Benzimidazole-derivatives as factor Xa inhibitors |
| 05/06/2009 | CN100484928C Thiadiazoline derivative |
| 05/06/2009 | CN100484524C Thiazolidine carboxamide derivatives as modulators of the prostaglandin receptor |
| 05/05/2009 | US7528167 Inhibitors of papilloma virus |
| 05/05/2009 | US7528163 N,N-Dibutyl-2-[3-(2,2-dimethylpropanoyl)-6-methoxy-1H-indazol-1-yl]acetamide; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, intraoccular pressure in the eye |
| 05/05/2009 | US7528160 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels |
| 05/05/2009 | US7528157 EP4 receptor antagonists |